TRAW Traws Pharma, Inc. logo

TRAW Traws Pharma, Inc.

Healthcare
$1.58+6.04%ClosedMarket Cap: $14.4M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

9

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+720,454

Shares Acquired

720,454

Shares Disposed

0

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Apr 28ORBIMED ADVISORS LLC10 percent ownerBuy1,793,187$1.671,793,187
Tue Apr 28ORBIMED ADVISORS LLC10 percent ownerBuy597,729$1.671,203,250
Wed Apr 08Parker Charles Nolanofficer: Chief Financial OfficerSell104,544$1.60104,544
Wed Apr 08Parker Charles Nolanofficer: Chief Financial OfficerSell61,571$2.3361,571
Wed Apr 08Parker Charles Nolanofficer: Chief Financial OfficerSell32,406$3.0132,406
Wed Apr 08Parker Charles Nolanofficer: Chief Financial OfficerSell15,393$0.0015,393
Wed Apr 08Parker Charles NolanSell0$0.000
Tue Mar 10STOVER JACK EdirectorSell33,435$1.6033,435
Tue Mar 10Shoemaker Mary TeresadirectorSell33,435$1.6033,435
Tue Mar 10Savchuk Nikolaydirector, officer: Chief Operating OfficerSell96,899$1.6096,899
Tue Mar 10Redfield Robertofficer: Chief Medical OfficerSell108,854$1.60108,854
Tue Mar 10Pauza Charles Davidofficer: Chief Science Officer VirologySell118,367$1.60118,367
Tue Mar 10Leaman John HarolddirectorSell33,435$1.6033,435
Tue Mar 10Dukes Iain D.director, officer: Chief Executive OfficerSell231,336$1.60231,336
Tue Mar 10Clarke TrafforddirectorSell33,435$1.6033,435